OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma
Salih Demir, Negin Razizadeh, Émilie Indersie, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Salih Demir, Negin Razizadeh, Émilie Indersie, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
Showing 8 citing articles:
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers
Ruhi Gulati, Yasmeen Fleifil, Katherine M. Jennings, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2300-2300
Open Access | Times Cited: 4
Ruhi Gulati, Yasmeen Fleifil, Katherine M. Jennings, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2300-2300
Open Access | Times Cited: 4
Hepatoblastoma: From Molecular Mechanisms to Therapeutic Strategies
Fan Ling, Jintong Na, Tieliu Shi, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 149-149
Open Access
Fan Ling, Jintong Na, Tieliu Shi, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 149-149
Open Access
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma
Salih Demir, Alina Hotes, Tanja Schmid, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Salih Demir, Alina Hotes, Tanja Schmid, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Strategies to enhance the response of liver cancer to pharmacological treatments
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 1
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 1
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1
F. Navarro Expósito, Miriam Redrado, Diego Serrano, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 1
F. Navarro Expósito, Miriam Redrado, Diego Serrano, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 1
Multi-Omics Integration for Liver Cancer Using Regression Analysis
Aditya Raj, Ruben C. Petreaca, Golrokh Mirzaei
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3551-3562
Open Access
Aditya Raj, Ruben C. Petreaca, Golrokh Mirzaei
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3551-3562
Open Access
Characterization of an Activated Metabolic Transcriptional Program in Hepatoblastoma Tumor Cells Using scRNA-seq
Claudia Monge, Raquel Francés, Agnès Marchio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13044-13044
Open Access
Claudia Monge, Raquel Francés, Agnès Marchio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13044-13044
Open Access
